ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹135 Cr | ₹124 Cr | ₹165 Cr | ₹222 Cr | ₹442 Cr |
What is the latest Total Non-Current Liabilities ratio of ORCHID PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹135 Cr |
Mar2024 | ₹124 Cr |
Mar2023 | ₹165 Cr |
Mar2022 | ₹222 Cr |
Mar2021 | ₹442 Cr |
How is Total Non-Current Liabilities of ORCHID PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹135 Cr | 8.46 | |
Mar2024 | ₹124 Cr | -24.43 | |
Mar2023 | ₹165 Cr | -25.96 | |
Mar2022 | ₹222 Cr | -49.71 | |
Mar2021 | ₹442 Cr | - |
Compare Total Non-Current Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,997.9 Cr | 11.1% | 4% | -50% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 11.1% |
4% |
-50% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses